Journal article
Outcome Analysis of Visual Acuity and Side Effect after Ruthenium-106 Plaque Brachytherapy for Medium-sized Choroidal Melanoma
Abstract
PURPOSE: The purpose of this study is to report on treatment outcomes for medium-sized choroidal melanoma treated with Ruthenium-106 (Ru-106) plaque brachytherapy.
METHODS: A retrospective case series of 28 patients received Ru-106 brachytherapy treatment for choroidal melanoma. The prescribed tumor dose was 85 Gy to a depth of 5 mm.
Authors
AlMahmoud T; Quinlan-Davidson S; Pond GR; Deschênes J
Journal
Middle East African Journal of Ophthalmology, Vol. 25, No. 2, pp. 103–107
Publisher
Wolters Kluwer
Publication Date
2018
DOI
10.4103/meajo.meajo_198_16
ISSN
0974-9233